Literature DB >> 24839223

The expression of FoxO1 in placenta and omental adipose tissue of gestational diabetes mellitus.

Y Xu1, B Jin1, L Sun1, H Yang2, X Cao1, G Zhang1.   

Abstract

To investigate FoxO1 expression in term placenta and omental adipose tissue between pregnant women with gestational diabetes mellitus (GDM) and those with normal glucose tolerance (control). The relationship between FoxO1 and tumor necrosis factor-α (TNF-α) in cultured trophoblast cells was also investigated.Maternal serum, term placenta and omental adipose tissue were collected from the GDM group (n=20) and the control group (n=20). Serum TNF-α, IL-6 and IL-1β concentration was measured. Fasting plasma glucose (FPG) and fasting serum insulin (FIN) were investigated to calculate an insulin resistance index (HOMA-IR). Immunohistochemistry (IHC) was performed to examine the localization of FoxO1 protein in the placenta and adipose tissue. Real time RT-PCR and Western blotting were used to compare the levels of FoxO1 and TNF-α gene and protein between the 2 groups. Trophoblast cells (HTR-8/SVneo and BeWo cells) were cultured to detect the regulation of TNF-α on FoxO1 expression. The effect of FoxO1 knockdown on TNF-α stimulated expression of pro-inflammatory cytokines was also investigated.Compared to control group, Serum TNF-α, IL-6 and IL-1β concentration was higher in GDM group. FoxO1 was expressed in both the placenta and omental adipose tissue. The gene and protein expression of FoxO1 and TNF-α was higher in the GDM group than the control group in both tissues. The expression of FoxO1 in the placenta was positively correlated with HOMA-IR and TNF-α. Stimulation of TNF-α gene increased the expression of FoxO1 in cultured trophoblast cells. FoxO1 deletion in these cells attenuated TNF-α-induced expression of the pro-inflammatory cytokines IL-1β and IL-6.FoxO1 has a potential role as a pro-inflammatory factor in GDM, and may be involved in the development of IR through interaction with TNF-α. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24839223     DOI: 10.1055/s-0034-1371830

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  4 in total

1.  Gut microbiota mediates the alleviative effect of polar lipids-enriched milk fat globule membrane on obesity-induced glucose metabolism disorders in peripheral tissues in rat dams.

Authors:  Tiange Li; Qichen Yuan; Han Gong; Min Du; Xueying Mao
Journal:  Int J Obes (Lond)       Date:  2022-01-29       Impact factor: 5.551

2.  Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes.

Authors:  Meenu Rohini Rajan; Elin Nyman; Preben Kjølhede; Gunnar Cedersund; Peter Strålfors
Journal:  J Biol Chem       Date:  2016-05-20       Impact factor: 5.157

Review 3.  Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives.

Authors:  Carmela Santangelo; Alessandra Zicari; Elisabetta Mandosi; Beatrice Scazzocchio; Emanuela Mari; Susanna Morano; Roberta Masella
Journal:  Br J Nutr       Date:  2016-02-16       Impact factor: 3.718

4.  LncRNA XIST serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell via miR-497-5p/FOXO1 axis.

Authors:  Yanchuan Li; Xiaohua Yuan; Ziyun Shi; Haili Wang; Duomei Ren; Ya Zhang; Yangyang Fan; Yanfeng Liu; Zhangxia Cui
Journal:  Cardiovasc Diagn Ther       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.